Precision BioSciences, Inc.
NASDAQ:DTIL
8.38 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 116.678 | 189.576 | 143.663 | 89.798 | 180.886 | 103.193 | 62.802 | 93.423 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 116.678 | 189.576 | 143.663 | 89.798 | 180.886 | 103.193 | 62.802 | 93.423 |
| Net Receivables
| 12.798 | 0.72 | 0.488 | 10 | 0.965 | 1.027 | 0.022 | 0.386 |
| Inventory
| 0 | 7.552 | 17.434 | 5.762 | 9.497 | 0 | 0 | 0 |
| Other Current Assets
| 6.883 | 1.257 | 0.169 | 0.004 | 2.324 | 11.455 | 1.507 | 0.593 |
| Total Current Assets
| 136.359 | 199.105 | 161.754 | 105.564 | 193.672 | 115.675 | 64.331 | 94.402 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 14.601 | 23.164 | 29.334 | 41.5 | 39.571 | 21.147 | 8.137 | 3.544 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0.4 | 1.348 | 2.048 | 1.373 | 1.432 | 1.466 | 0.09 | 0 |
| Goodwill and Intangible Assets
| 0.4 | 1.348 | 2.048 | 1.373 | 1.432 | 1.466 | 0.09 | 0 |
| Long Term Investments
| 8.196 | 4.748 | 6.842 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| -0 | 0 | 6.879 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.225 | 9.804 | 4.641 | 1.721 | 0.558 | 0.312 | 0.124 | 0.468 |
| Total Non-Current Assets
| 23.422 | 39.064 | 49.744 | 44.594 | 41.561 | 22.925 | 8.351 | 4.012 |
| Total Assets
| 159.781 | 238.169 | 211.498 | 150.158 | 235.233 | 138.6 | 72.682 | 98.414 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 2.968 | 1.225 | 1.144 | 0.792 | 2.037 | 2.218 | 1.806 | 1.286 |
| Short Term Debt
| 23.545 | 2.037 | 1.822 | 1.933 | 6.825 | 3.251 | 1.506 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 12.035 | 46.192 | 21.244 | 30.236 | 16.486 | 8.436 | 5.824 | 6.209 |
| Other Current Liabilities
| 11.439 | 10.21 | 11.77 | 9.868 | 1.584 | 0.17 | 0.067 | 0.845 |
| Total Current Liabilities
| 49.987 | 59.664 | 35.98 | 42.829 | 26.932 | 14.075 | 9.203 | 8.34 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 7.723 | 24.999 | 7.291 | 8.586 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 83.082 | 92.872 | 77.015 | 53.926 | 65.895 | 82.807 | 88.596 | 94.39 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.128 | 0.201 | 0.044 | 0.392 | 4.092 | 1.758 | 1.252 | 0.433 |
| Total Non-Current Liabilities
| 90.933 | 118.072 | 84.35 | 62.904 | 69.987 | 84.565 | 89.848 | 94.823 |
| Total Liabilities
| 140.92 | 177.736 | 120.33 | 105.733 | 96.919 | 98.64 | 99.051 | 103.163 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0.005 | 0.003 | 0.003 |
| Common Stock
| 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -489.631 | -428.312 | -316.675 | -286.073 | -177.067 | -85.187 | -39.111 | -18.009 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -5.484 | -3.193 | 0 |
| Other Total Stockholders Equity
| 508.491 | 488.744 | 407.843 | 330.498 | 315.381 | 130.626 | 15.932 | 13.257 |
| Total Shareholders Equity
| 18.861 | 60.433 | 91.168 | 44.425 | 138.314 | 39.96 | -26.369 | -4.749 |
| Total Equity
| 18.861 | 60.433 | 91.168 | 44.425 | 138.314 | 39.96 | -26.369 | -4.749 |
| Total Liabilities & Shareholders Equity
| 159.781 | 238.169 | 211.498 | 150.158 | 235.233 | 138.6 | 72.682 | 98.414 |